DENVER, Colo., Nov 10, 2023 (www.247marketnews.com)- The following companies were among the listings that we covered this week; Cardio Diagnostics (NASDAQ: CDIO), MSP Recovery Inc (NASDAQ: LIFW), PaxMedica (NASDAQ: PXMD), Intelligent Bio Solutions (NASDAQ: INBS), Blink Charging’s (NASDAQ: BLNK), and Palantir Technologies (NYSE: PLTR).
We expect the news to slow down during earnings report season, but the drop in non-report updates is larger than we expected.
In last week’s wrap, we mentioned that a surprising number of the small-cap runners that we covered were nicely following through for longer term runs and we’ll cover a few of those.
Our week started by covering Organigram Holdings (NASDAQ: OGI) receiving a C$124.6 million follow-on strategic equity investment from BT DE Investments Inc., a wholly-owned subsidiary of British American Tobacco PLC (NYSE: BTI). Organigram Holdings was trading at $1.31, up $0.15 (+12.93%), on 145.2K premarket shares traded, when we covered the news, and it hit a premarket high of $1.72. It pulled back to open the regular trading session at $1.52, hit its regular session high of $1.60, fifteen minutes into the session and spent the rest of the day drifting down to close at $1.38, up $0.22 (+18.97%), on trading volume of 43,449,192 shares.
After spotting and covering Cardio Diagnostics (NASDAQ: CDIO) last week, when it was 30-cents, we noticed that was on the move, again, when it was trading at $0.50, up $0.13 (+34.35%), on 5.7M shares traded. It hit its $0.775 high just before lunch, held on to most of its gains to close at $0.68, up $0.3056 (+81.62%), on 104,142,617 shares traded, and traded higher in afterhours trading.
We were happy to see that the day’s big winner was MSP Recovery Inc (NASDAQ: LIFW), which we covered last week when it was trading at $2.78. It skyrocketed to $17.4798, before closing at $9.65, up $6.91 (+252.19%), on 64,047,534 shares traded.
Since we were late covering PaxMedica’s (NASDAQ: PXMD) peer-reviewed journal publication news, we waited for it to pullback from its $6.90 premarket high and covered it when it was trading at $5.87, up $2.82 (+92.46%) on 5.55M premarket shares. We cautioned that PXMD’s pattern has been popping and losing most of its gains in the same day.
Despite a few trading halts PXMD hit a $10.26 high, about 25 minutes into the regular trading session, and it mostly drifted down from there to close at $4.50, up $1.45 (+47.54%), on trading volume of 35,202,542 shares.
We covered that Baiyu Holdings (NASDAQ: BYU) was adding to the gains it made on Tuesday, when it was trading at $3.15, up $0.40 (+14.5%) on 535.6K premarket shares. It hit a premarket high of $4.20, but couldn’t keep it going in the regular session.
While most listings weren’t very exciting in the regular session, but some of the that we covered earlier in the week, like Senti’s (NASDAQ: SNTI) news on Tuesday and it followed through on Wednesday. It hit a 74-cent high and closed at $0.68 (+30.77%), on 28,637,059 shares traded, and Cardio Diagnostics (NASDAQ: CDIO) continued to run on Tuesday and by Wednesday it hit a high of $1.82.
Intelligent Bio Solutions (NASDAQ: INBS) was trading at $0.43, up $0.20 (+87.75%), on 32.7M shares traded, after reporting positive Q1 2024 financial results and operational highlights. It hit a high of $0.7806, about two hours later, and closed at $0.437, up $0.21 (+92.51%), on trading volume of 220,987,259 shares.
We covered Blink Charging’s (NASDAQ: BLNK) third quarter financial results, when it was trading at $2.76, up $0.30 (+12.2%) on 250K premarket shares. We stated that its setup was favorable to move above $3. It opened at $2.87, hit a high of $3.40, and closed at $3.07, up $0.61 (+24.80%), on 20,554,021 shares traded.
We spotted AVITA Medical’s (NASDAQ: RCEL) move when it was trading at $1.20, up $0.50 (+70.70%), on 15.89M shares traded. It hit a $2.04 high, but the multiple trading halts killed its momentum an it closed at $1.31, up $0.623 (+90.68%), on 71,870,181 shares traded.
Marpai Inc (NASDAQ: MRAI) was trading at $0.57, up $0.18 (+48.3%), on 26.1M shares traded, when we mentioned their trading. It mostly traded sideways for the next 90 minutes, then shot up to 90-cents and closed at $0.6845, at $0.3058 (+80.75%), on 53,847,052 shares traded. It’s trading higher in afterhours trading, currently at 74-cents.
Intelligent Bio Solutions Inc (NASDAQ: INBS) is trading at $0.63, up $0.19 (+44.16%), on 62.55M shares traded, after yesterday’s Q1 and operational highlights announcements.
VIZIO Holding Corp (NYSE: VZIO) is trading at $6.65, up $1.37 (+25.96%), on 1.63M shares traded.
As we stated in the intro, a bunch of the listings that we covered last week were following through, this week. A few examples include BioXcel Therapeutics Inc. (NASDAQ: BTAI), Cellectis (NASDAQ: CLLS), TG Therapeutics (NASDAQ: TGTX), and Palantir Technologies (NYSE: PLTR), which looks poised to hit a new 52-week high after its Q3 report included raising its outlook.
Thank you for joining us this week. Have a great weekend and get ready for next week!
Connect with 24/7 Market News:
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community.
24/7 Market News (24/7MN) is a third-party publisher and online news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ, and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7 MN is not affiliated with any company written about in this release and owns no shares of stock. 24/7MN’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.
The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable.
The stocks and strategies discussed are simply ideas only and are in no way financial advice or recommendations. The author may or may not at any time be holding securities discussed. The author may or may not enter trades in the stocks mentioned. Some positions in mentioned stocks may already be held or are being adjusted or are simply examples, ideas or discussion topics. You are always trading at your own risk.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
24/7 Market News